In addition, the upregulation of miR‐196b led to the downregulation of BCR‐ABL, a critical factor for the survival of leukemic cells in CML (Taverna et al. 2016, 2015). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.